TKNO: Alpha Teknova, Inc. Stock

by  •  • Comments Off on TKNO: Alpha Teknova, Inc. Stock

SIC 2835 – In Vitro and In Vivo Diagnostic Substances

Valuation
Market Cap ($M) 244.13
Enterprise Value ($M) 238.81
Book Value ($M) 78.93
Book Value / Share 1.48
Price / Book 3.09
NCAV ($M) -1.14
NCAV / Share -0.02
Price / NCAV -213.96

Profitability (mra)
Return on Invested Capital (ROIC) -0.31
Return on Assets (ROA) -0.26
Return on Equity (ROE) -0.40

Liquidity (mrq)
Quick Ratio 3.28
Current Ratio 4.76

Balance Sheet (mrq) ($M)
Current Assets 35.28
Assets 115.35
Liabilities 36.42
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 36.68
Operating Income -31.20
Net Income -36.78

Cash Flow Statement (mra) ($M)
Cash From Operations -18.70
Cash from Investing -7.74
Cash from Financing 12.80

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
07-19 13D Telegraph Hill Partners IV, L.P. 70.80 47.21

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-03-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-09-06 15,118 73,181 20.66
2024-09-05 11,548 63,839 18.09
2024-09-04 12,022 76,484 15.72
2024-09-03 29,675 322,328 9.21

(click for more detail)

Similar Companies
TARA – Protara Therapeutics, Inc. TBPH – Theravance Biopharma, Inc.
TCRX – TScan Therapeutics, Inc. TLPH – Talphera, Inc.
TNGX – Tango Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io